These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10953626)

  • 1. [Hormonal profile in men with premature androgenic alopecia].
    Stárka L; Hill M; Polácek V
    Sb Lek; 2000; 101(1):17-22. PubMed ID: 10953626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
    Starka L; Duskova M; Cermakova I; Vrbiková J; Hill M
    Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal profile of men with premature balding.
    Stárka L; Cermáková I; Dusková M; Hill M; Dolezal M; Polácek V
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):24-8. PubMed ID: 14758568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The polycystic ovary syndrome and its male equivalent].
    Dusková M; Hill M; Stráka L
    Cas Lek Cesk; 2007; 146(3):251-5. PubMed ID: 17419309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endocrine constellation in androgenetic alopecia in the female].
    Schmidt JB
    Wien Klin Wochenschr; 1987 Jan; 99(1):21-4. PubMed ID: 3105180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What may be the markers of the male equivalent of polycystic ovary syndrome?
    Dusková M; Cermáková I; Hill M; Vanková M; Sámalíková P; Stárka L
    Physiol Res; 2004; 53(3):287-94. PubMed ID: 15209536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal parameters in androgenetic hair loss in the male.
    Schmidt JB; Lindmaier A; Spona J
    Dermatologica; 1991; 182(4):214-7. PubMed ID: 1832108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal profile in Indian men with premature androgenetic alopecia.
    Narad S; Pande S; Gupta M; Chari S
    Int J Trichology; 2013 Apr; 5(2):69-72. PubMed ID: 24403767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].
    Brailly-Tabard S; Trabado S; Khallouf O
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S329-33. PubMed ID: 19268210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trace elements content and hormonal profiles in women with androgenetic alopecia.
    Skalnaya MG; Tkachev VP
    J Trace Elem Med Biol; 2011 Jan; 25 Suppl 1():S50-3. PubMed ID: 21167696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
    Hampl R; Snajderova M; Lebl J; Lisa L; Dvorakova M; Hill M; Sulcova J; Starka L
    Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
    Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
    Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.